Who owns ADAGIO THERAPEUTICS INC?
- Ticker: IVVD
- CUSIP Number: 00534a102
Tip: Access positions for across all investors
Analyze quarterly positions in Adagio Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Adagio Therapeutics stock
Who bought or sold ADAGIO THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Maverick Capital | 9.3M | $37M | 77% | Dec 2023 |
|
M28 Capital Management | 9.2M | $36M | 0% | Dec 2023 |
|
Alphabet | 5.7M | $22M | 0% | Dec 2023 |
|
OrbiMed Advisors | 4.1M | $16M | -22% | Dec 2023 |
|
683 Capital Management | 3.6M | $14M | -10% | Dec 2023 |
|
Vanguard Group | 2.5M | $9.9M | 1% | Dec 2023 |
|
Redmile Group | 1.4M | $5.7M | 0% | Dec 2023 |
|
Millennium Management | 456k | $1.8M | -58% | Dec 2023 |
|
Jacobs Levy Equity Management | 358k | $1.4M | -14% | Dec 2023 |
|
Charles Schwab Investment Management | 304k | $1.2M | 14% | Dec 2023 |
|
Citigroup | 270k | $1.1M | -47% | Dec 2023 |
|
Acuitas Investments | 209k | $822k | 0% | Dec 2023 |
|
Jane Street | 194k | $763k | 520% | Dec 2023 |
|
Squarepoint Ops | 102k | $403k | -50% | Dec 2023 |
|
Balyasny Asset Management | 87k | $342k | 100% | Dec 2023 |
|
a16z Perennial Management | 80k | $315k | 100% | Dec 2023 |
|
Barclays | 72k | $285k | 100% | Dec 2023 |
|
Two Sigma Investments | 57k | $224k | 100% | Dec 2023 |
|
Goldman Sachs Group | 54k | $213k | 136% | Dec 2023 |
|
Citadel Advisors | 47k | $186k | 100% | Dec 2023 |
|
Bank of America Corporation | 45k | $176k | 1336% | Dec 2023 |
|
Marquette Asset Management | 43k | $170k | 0% | Dec 2023 |
|
Marshall Wace | 29k | $116k | 100% | Dec 2023 |
|
Cubist Systematic Strategies | 26k | $101k | 227% | Dec 2023 |
|
Bank of New York Mellon | 26k | $101k | 0% | Dec 2023 |
|
JustInvest | 18k | $69k | -13% | Dec 2023 |
|
Laurion Capital Management | 16k | $63k | 100% | Dec 2023 |
|
UBS Group | 15k | $57k | 1158% | Dec 2023 |
|
Jpmorgan Chase & Co | 13k | $52k | -37% | Dec 2023 |
|
Mariner Wealth Advisors | 11k | $41k | 3% | Dec 2023 |
|
Naples Global Advisors | 10k | $39k | -50% | Dec 2023 |
|
Rhumbline Advisers | 7.3k | $29k | 0% | Dec 2023 |
|
Advisor Group Holdings | 6.3k | $25k | 1260% | Dec 2023 |
|
Loring Wolcott Coolidge Fa | 2.0k | $4.4k | 100% | Mar 2024 |
|
Point72 Asia | 1.8k | $7.0k | 100% | Dec 2023 |
|
Royal Bank of Canada | 675.00 | $3.0k | 13400% | Dec 2023 |
|
Wells Fargo & Company | 674.00 | $2.7k | -24% | Dec 2023 |
|
Aspire Private Capital | 200.00 | $888.000000 | 0% | Mar 2024 |
|
Glassman Wealth Services | 200.00 | $788.000000 | 0% | Dec 2023 |
|
NISA Investment Advisors | 6.00 | $24.000000 | 0% | Dec 2023 |
|
Farther Finance Advisors | 1.00 | $4.000000 | 100% | Dec 2023 |
|
Who sold out of Adagio Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Tang Capital Management | Sep 2023 | 367k | $623k |
Shay Capital | Sep 2023 | 15k | $25k |
Point72 Asset Management | Sep 2023 | 11k | $19k |
Deutsche Bank Aktiengesellschaft | Sep 2023 | 3.0k | $5.0k |
China Universal Asset Management | Sep 2023 | 2.8k | $5.0k |
Simplex Trading | Sep 2023 | 198.00 | $0 |